Literature DB >> 28639163

agr functionality affects clinical outcomes in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia.

C K Kang1,2, Y K Kim3, S-I Jung4, W B Park2,5, K-H Song1,2, K-H Park4, P G Choe2,5, H-C Jang6, S Lee7, Y-S Kim8, Y G Kwak9, K T Kwon10, S Kiem11, C-J Kim12, E S Kim13,14, H B Kim1,2.   

Abstract

Methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) often persists despite appropriate antibiotic therapy. It is unclear what microbiological factors contribute to poor clinical outcomes in persistent MRSAB (pMRSAB). We aimed to identify clinical and microbiological risk factors for in-hospital mortality in pMRSAB. We analysed MRSAB cases prospectively collected between 2009 and 2016 at 11 hospitals in Korea, defining cases of pMRSAB as MRSAB lasting ≥5 days despite administration of effective antibiotics. The first blood isolates from the pMRSAB cases were tested for staphylococcal cassette chromosome mec type, staphylococcal protein A type, accessary gene regulator (agr) type, genes for Panton-Valentine leukocidin and phenol-soluble modulin-mec, vancomycin minimum inhibitory concentration, vancomycin heteroresistance, and agr functionality. We also collected clinical information for each case. Of 960 MRSAB cases, 152 pMRSAB were finally eligible. Univariable analysis revealed that in-hospital mortality was significantly associated with Charlson's comorbidity-weighted index (CCWI) score, Pitt bacteremia score, sequential organ failure assessment score, presentation with septic shock, pneumonia, agr dysfunction, and vancomycin heteroresistance. Bone and joint infections were negatively associated with in-hospital mortality. Multivariable analysis revealed the following independent risk factors for in-hospital mortality: CCWI score [adjusted odds ratio (aOR), per one point, 1.25; 95% confidence interval (CI), 1.08-1.44; P = 0.003), Pitt bacteremia score (aOR, per one point, 1.33; 95% CI, 1.09-1.62; P = 0.005), non-eradicated foci of infection (aOR, 3.12; 95% CI, 1.18-8.27; P = 0.022), and agr dysfunction (aOR, 2.48; 95% CI, 1.12-5.47; P = 0.025). agr dysfunction is an independent risk factor for in-hospital mortality in pMRSAB.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28639163     DOI: 10.1007/s10096-017-3044-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

1.  agr dysfunction affects staphylococcal cassette chromosome mec type-dependent clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Chang Kyung Kang; Jeong Eun Cho; Yoon Jeong Choi; Younghee Jung; Nak-Hyun Kim; Chung-Jong Kim; Taek Soo Kim; Kyoung-Ho Song; Pyoeng Gyun Choe; Wan Beom Park; Ji-Hwan Bang; Eu Suk Kim; Kyoung Un Park; Sang Won Park; Nam-Joong Kim; Myoung-Don Oh; Hong Bin Kim
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

3.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

4.  Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.

Authors:  Sheng-Hsiang Lin; Wan-Hsiu Liao; Chih-Cheng Lai; Chun-Hsing Liao; Che-Kim Tan; Cheng-Yi Wang; Yu-Tsung Huang; Po-Ren Hsueh
Journal:  J Antimicrob Chemother       Date:  2010-05-28       Impact factor: 5.790

5.  Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes.

Authors:  Claudia Hawkins; Jenny Huang; Nancy Jin; Gary A Noskin; Teresa R Zembower; Maureen Bolon
Journal:  Arch Intern Med       Date:  2007-09-24

6.  Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  O Gasch; M Camoez; M A Domínguez; B Padilla; V Pintado; B Almirante; J A Lepe; M Lagarde; E Ruiz de Gopegui; J A Martínez; M Montejo; J Torre-Cisneros; A Arnáiz; M A Goenaga; N Benito; J Rodríguez-Baño; M Pujol
Journal:  J Antimicrob Chemother       Date:  2013-02-12       Impact factor: 5.790

7.  International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections.

Authors:  David L Paterson; Wen-Chien Ko; Anne Von Gottberg; Sunita Mohapatra; Jose Maria Casellas; Herman Goossens; Lutfiye Mulazimoglu; Gordon Trenholme; Keith P Klugman; Robert A Bonomo; Louis B Rice; Marilyn M Wagener; Joseph G McCormack; Victor L Yu
Journal:  Ann Intern Med       Date:  2004-01-06       Impact factor: 25.391

8.  Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  Kyoung-Ho Song; Hong Bin Kim; Hyung-sook Kim; Myung Jin Lee; Younghee Jung; Gayeon Kim; Jeong-Hwan Hwang; Nak-Hyun Kim; Moonsuk Kim; Chung-Jong Kim; Pyoeng Gyun Choe; Jae-Yong Chung; Wan Beom Park; Eu Suk Kim; Kyoung Un Park; Nam Joong Kim; Eui-Chong Kim; Myoung-don Oh
Journal:  Int J Antimicrob Agents       Date:  2015-10-17       Impact factor: 5.283

9.  Characteristics of invasive Staphylococcus aureus infections in three regions of Korea, 2009-2011: a multi-center cohort study.

Authors:  Kyoung-Ho Song; Eu Suk Kim; Hye-Yun Sin; Kyung-Hwa Park; Sook-In Jung; Nara Yoon; Dong-Min Kim; Chang Seop Lee; Hee-Chang Jang; Yoonseon Park; Kkot Sil Lee; Yee Gyung Kwak; Jae Hoon Lee; Seong Yeon Park; Minkyo Song; Sue K Park; Yeong-Seon Lee; Hong Bin Kim
Journal:  BMC Infect Dis       Date:  2013-12-10       Impact factor: 3.090

Review 10.  What role does the quorum-sensing accessory gene regulator system play during Staphylococcus aureus bacteremia?

Authors:  Kimberley L Painter; Aishwarya Krishna; Sivaramesh Wigneshweraraj; Andrew M Edwards
Journal:  Trends Microbiol       Date:  2014-10-06       Impact factor: 17.079

View more
  11 in total

1.  Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease.

Authors:  Chang Kyung Kang; Yee Gyung Kwak; Youngmi Park; Kyoung-Ho Song; Eu Suk Kim; Sook-In Jung; Kyung-Hwa Park; Wan Beom Park; Nam Joong Kim; Young Keun Kim; Hee-Chang Jang; Shinwon Lee; Jae Hyun Jeon; Ki Tae Kwon; Chung-Jong Kim; Yeon-Sook Kim; Hong Bin Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-17       Impact factor: 3.267

2.  A Prospective Cohort Study of Durations of Staphylococcus aureus Bacteremia According to Different Phenotypes and a New Concept of Persistent Bacteremia.

Authors:  Chang Kyung Kang; Kyoung-Ho Song; Seong Eun Kim; Eu Suk Kim; Wan Beom Park; Kyung-Hwa Park; Shin Hye Chun; Shinwon Lee; Chong Rae Cho; Seung Ji Kang; Myoung-Don Oh; Yeon-Sook Kim; Sun Hee Lee; Yee Gyung Kwak; Hee-Chang Jang; Chung-Jong Kim; Young Keun Kim; Ji-Hwan Bang; Sungmin Kiem; Ki Tae Kwon; Younghee Jung; Yu Min Kang; Sook-In Jung; Hong Bin Kim
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

Review 3.  Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms.

Authors:  Jakub M Kwiecinski; Alexander R Horswill
Journal:  Curr Opin Microbiol       Date:  2020-03-12       Impact factor: 7.934

Review 4.  Mechanisms and clinical relevance of bacterial heteroresistance.

Authors:  Dan I Andersson; Hervé Nicoloff; Karin Hjort
Journal:  Nat Rev Microbiol       Date:  2019-06-24       Impact factor: 60.633

5.  Host-Pathogen-Treatment Triad: Host Factors Matter Most in Methicillin-Resistant Staphylococcus aureus Bacteremia Outcomes.

Authors:  M Cristina Vazquez Guillamet; Rodrigo Vazquez; Benjamin Deaton; Jenny Shroba; Laia Vazquez; Renee-Claude Mercier
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

6.  The Agr Quorum Sensing System Represses Persister Formation through Regulation of Phenol Soluble Modulins in Staphylococcus aureus.

Authors:  Tao Xu; Xu-Yang Wang; Peng Cui; Yu-Meng Zhang; Wen-Hong Zhang; Ying Zhang
Journal:  Front Microbiol       Date:  2017-11-07       Impact factor: 5.640

7.  Challenges and Limitations of Anti-quorum Sensing Therapies.

Authors:  Paweł Krzyżek
Journal:  Front Microbiol       Date:  2019-10-31       Impact factor: 5.640

8.  Bacterial virulence plays a crucial role in MRSA sepsis.

Authors:  Gordon Y C Cheung; Justin S Bae; Ryan Liu; Rachelle L Hunt; Yue Zheng; Michael Otto
Journal:  PLoS Pathog       Date:  2021-02-25       Impact factor: 6.823

9.  Reductive evolution of virulence repertoire to drive the divergence between community- and hospital-associated methicillin-resistant Staphylococcus aureus of the ST1 lineage.

Authors:  Marina Farrel Côrtes; Ana Maria N Botelho; Paula Terra Bandeira; William Mouton; Cedric Badiou; Michèle Bes; Nicholas C B Lima; André Elias R Soares; Rangel C Souza; Luiz G P Almeida; Patricia Martins-Simoes; Ana T R Vasconcelos; Marisa F Nicolás; Frédéric Laurent; Paul J Planet; Agnes M S Figueiredo
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

10.  Dysfunctional accessory gene regulator (agr) as a prognostic factor in invasive Staphylococcus aureus infection: a systematic review and meta-analysis.

Authors:  Soon Ok Lee; Shinwon Lee; Jeong Eun Lee; Kyoung-Ho Song; Chang Kyung Kang; Yu Mi Wi; Rafael San-Juan; Luis E López-Cortés; Alicia Lacoma; Cristina Prat; Hee-Chang Jang; Eu Suk Kim; Hong Bin Kim; Sun Hee Lee
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.